Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Bhojwani

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Blood Advances|June 28, 2019
Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemiaAmy K Keating, Nathan Gossai, Christine L Phillips, et al.
The Journal of Molecular Diagnostics : JMD|November 19, 2023
Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical LaboratoryZunsong Hu, Alexandra E Kovach, Venkata Yellapantula, et al.
The New England Journal of Medicine|December 25, 2009
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenzaAditya H Gaur, Bindiya Bagga, Subrata Barman, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Pediatric acute lymphoblastic leukemiaWilliam L Carroll, Deepa Bhojwani, Dong-Joon Min, et al.
Pediatric Hematology and Oncology|December 1, 2017
Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working GroupDeepa Bhojwani, Michael J Burke, Terzah Horton, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 27, 2021
Perspectives of Pediatric Providers Regarding Clinical Use of PharmacogeneticsKayleigh Avello, Megan Bell, Quinn Stein, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2025
Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia SubtypesTravis H Smith, Jeffrey Jean, Stephen Phan, et al.
Blood Cancer Journal|September 8, 2018
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemiaLia Gore, Franco Locatelli, Gerhard Zugmaier, et al.
Frontiers in Cell and Developmental Biology|April 21, 2023
Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemiaHeather A Ogana, Samantha Hurwitz, Chih-Lin Hsieh, et al.
Experimental and Therapeutic Medicine|December 22, 2021
<i>In vitro</i> and <i>in vivo</i> effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Blood Advances|June 28, 2019
Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemiaAmy K Keating, Nathan Gossai, Christine L Phillips, et al.
The Journal of Molecular Diagnostics : JMD|November 19, 2023
Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical LaboratoryZunsong Hu, Alexandra E Kovach, Venkata Yellapantula, et al.
The New England Journal of Medicine|December 25, 2009
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenzaAditya H Gaur, Bindiya Bagga, Subrata Barman, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Pediatric acute lymphoblastic leukemiaWilliam L Carroll, Deepa Bhojwani, Dong-Joon Min, et al.
Pediatric Hematology and Oncology|December 1, 2017
Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working GroupDeepa Bhojwani, Michael J Burke, Terzah Horton, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 27, 2021
Perspectives of Pediatric Providers Regarding Clinical Use of PharmacogeneticsKayleigh Avello, Megan Bell, Quinn Stein, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2025
Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia SubtypesTravis H Smith, Jeffrey Jean, Stephen Phan, et al.
Blood Cancer Journal|September 8, 2018
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemiaLia Gore, Franco Locatelli, Gerhard Zugmaier, et al.
Frontiers in Cell and Developmental Biology|April 21, 2023
Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemiaHeather A Ogana, Samantha Hurwitz, Chih-Lin Hsieh, et al.
Experimental and Therapeutic Medicine|December 22, 2021
<i>In vitro</i> and <i>in vivo</i> effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Pageof 13